Pre-Filled Syringes Conference returns to London next January. The meeting will focus on the solutions to accelerate PFS development and technology advancements

LONDON, LONDON, UK, October 8, 2015 /EINPresswire.com/ -- Pre-Filled Syringes 2016 returns to Copthorne Tara Hotel, Kensington, London, UK, next January, to look beyond upcoming obstacles which will help industry players prepare for better PFS solutions. With a selected 100+ representatives from the world’s leading pharmaceutical, biotech and device manufacturers, delegates will learn the A-Z journey of PFS. This strategic meeting will enable attendees to bridge the technical and commercial gap to ensure you stay ahead of competition.

The 2016 agenda includes 16+ case studies from PFS leaders, 2 exclusive interactive workshops and over 4hr unrivalled networking time. Further information available at the event website www.pre-filled-syringes.com/einpr

The exceptional speaker panel 2016 will include elite PFS experts from Novartis Pharma AG, Allergan, MHRA, GSK R&D, Sanofi R&D, Amgen, F. Hoffmann -La Roche Inc, GSK, Barts Health Pharmaceutics and many more.

Event official website: www.pre-filled-syringes.com/EINPR

As well as receiving the latest information about PFS, this conference will present attendees with the opportunity to network with Directors, VPs, Chiefs, Heads, Principals and Managers of Pre-Filled Syringes, Drug Device Engineering, Packaging, Production, R&D, Bioprocessing, QA/QC, Business Development and many more.

Key benefits for attending the 2016 conference include:
• Spotlight case study from F. Hoffmann-La Roche on usability challenges of PFS on combination products
• Amgen to demonstrate how human factor engineering can reduce risks by design
• Sanofi R&D showcases the path to auto injectors
• Allergan explains their safety assessment of E&L when developing PFS drug products
• GSK presents how to conduct thorough visual inspection of PFS
• Hear from regulator and join interactive discussions to benchmark your PFS strategy against peers'

In addition to being provided with information on the accelerating journey of PFS development, delegates have the option to take part in two interactive half-day pre-conference workshops. Places for these workshops are strictly limited to ensure an interactive dialogue and optimal learning outcome for all who choose to participate.

1. Pre-Filled Syringes: Development, Packaging and Regulatory Considerations
Led by: Horst Koller, CEO, HK Packaging Consulting GmbH

2. Bridging the Gap - From Formulation to PF'S Device Engineering
Led by: Jean-Rene Authelin, Global Head, Pharmaceutical Engineering, Sanofi R&D

Pre-Filled Syringes 2016 Conference is proudly sponsored by BD Medical, Medical Device Usability, Mitsubishi Gas Chemical, Nemera, Nipro Pharma Packaging, Noxilizer, Owen Mumford and West Pharmaceuticals Services.

Limited sponsorship opportunities available. For further information contact Alia Malick, Director, on +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk

Delegate enquiries: Contact Fateja Begum on + 44 (0) 207 27 6184, fbegum@smi-online.co.uk
For more information or to register visit the website at www.pre-filled-syringes.com/EINPR

8th annual Pre-Filled Syringes Conference
27th - 28th January 2016
London, UK
www.pre-filled-syringes.com/EINPR
Contact e-mail: jrotar@smi-online.co.uk
Contact number: Fateja Begum: +44 (0) 20 7827 6184

------------------------- END OF PRESS RELEASE--------------------------
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Julia Rotar
SMi Group Ltd
+44 (0) 207 827 6088
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.